Beta Bionics, Inc. (BBNX): Total Assets
$328.74M
As of 2025-12-31
$292.39M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $328.74M | +119.7% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $149.65M | +36.0% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $110.04M | n/a | 2025-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $328.74M | +119.7% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $105.56M | +11.5% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $358.46M | +21.2% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $129.29M | -20.6% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $190.27M | -6.2% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $403.17M | -15.9% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $123.63M | +61.4% |
| Iradimed Corp (IRMD) | 2025-12-31 | $108.78M | +10.6% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $81.42M | -6.0% |
Compare BBNX, NPCE, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗